Company
ItalyPublic company, OTC: DSRNYDiaSorin S.p.A. (OTC: DSRNY), Saluggia, Italy – FDA Inspections
Inspection records and compliance data for DiaSorin S.p.A. in Saluggia. 4 FDA inspections on record, last inspected February 06, 2023. Publicly traded as OTC: DSRNY.
Company Profile
This profile covers DiaSorin S.p.A. based in Saluggia, Italy.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected May 13, 2009. Last inspected February 6, 2023.
Most cited issue areas
- General1 inspection
- Management review - Lack of or inadequate procedures1 inspection
- Procedures for product review,disposition lack of/inadequate1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 6, 2023 | NAI | Medical Devices & Rad Health · Compliance: Devices | 1199544 |
| April 11, 2019 | Not classified | Medical Devices & Rad Health | 1092467 |
| January 24, 2013 | VAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 820927 |
| May 13, 2009 | NAI | Medical Devices & Rad Health · Compliance: Devices | 584985 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
DiaSorin S.p.A.
Stock ticker
DSRNY
Exchange
OTC
Price as of
November 6, 2026
FEI Number
3002808212
Address
Via Crescentino Snc, Saluggia, Italy
Country
Italy
ID: 72c841b1-5e19-46a3-9833-bf734c922895